Venue
Online Event

What is Qwoted?

Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.

Event Date Thu Apr 15 CET - Fri Apr 16 CET (over 3 years ago)
In your timezone (EST): Thu Apr 15 8:30am - Fri Apr 16 1:20pm
Location Online Event
Region EMEA
Details

Advancing qPCR and dPCR technological developments and its applications in oncology and infectious disease diagnostics

As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

MarketsandMarkets are proud to host its inaugural “qPCR and dPCR Virtual Conference”. The conference will focus on the latest developments in digital and real time PCR and also, it’s application in cancer diagnosis and infectious disease diagnostics.

Speakers

2021 Speakers

David Zarling
CEO, Colby Pharmaceuticals, USA

Loo Keat Wei
Assistant Professor, Faculty of Science, Universiti Tunku Abdul Rahman (UTAR), Malaysia

Antoinette Perry
Lecturer, Cancer Biology, University College Dublin, Ireland

Laxmi Silwal-Pandit
Department of Cancer Genetics, Oslo University Hospital, Norway

Valerie Taly
Research Director, CNRS, INSERM, France

Andreas Weinhaeusel
Thematic Coordinator, Molecular Diagnostics, AIT Austrian Institute of Technology, Austria

Pawel Debski
Senior Analyst, Scope Fluidics, Poland

Sponsors & Partners

2021 Partners

MEDIA PARTNERS:
• PharmaVOICE
• PharmaTutor
• Pharma Journalist